Andrew M. Scott
Impact in
- Radiology, Nuclear Medicine and Imaging top 0.05%
- Monoclonal and Polyclonal Antibodies Research
- Medical Imaging Techniques and Applications
- Radiopharmaceutical Chemistry and Applications
- Oncology top 0.2%
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
Papers in
-
- Radiopharmaceutical Chemistry and Applications 123
- Monoclonal and Polyclonal Antibodies Research 113
- Medical Imaging Techniques and Applications 105
- Radiomics and Machine Learning in Medical Imaging 42
- Oncology 187
- HER2/EGFR in Cancer Research 71
- CAR-T cell therapy research 39
- Co-authors
- Lloyd J. Old (52 shared papers)Jedd D. Wolchok (2 shared papers)Hui Gan (66 shared papers)Sze Ting Lee (53 shared papers)Terrance G. Johns (31 shared papers)Antony W. Burgess (23 shared papers)Sagun Parakh (22 shared papers)Richard J. Simpson (5 shared papers)
- Journals
- Journal of Clinical Oncology (32 papers)European Journal of Nuclear Medicine and Molecular Imaging (25 papers)Journal of Nuclear Medicine (25 papers)Nuclear Medicine and Biology (15 papers)The Lancet Oncology (11 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Andrew M. Scott
619 papers receiving 20.8k citations
Andrew M. Scott's Hit Papers
Peers
Comparison fields: 5 of 203
- Radiology, Nuclear Medicine and Imaging 7.4k
- Oncology 6.0k
- Cancer Research 2.4k
- Genetics 1.3k
- Immunology 2.5k
Countries citing papers authored by Andrew M. Scott
This map shows the geographic impact of Andrew M. Scott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew M. Scott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew M. Scott more than expected).
Fields of papers citing papers by Andrew M. Scott
This network shows the impact of papers produced by Andrew M. Scott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew M. Scott. The network helps show where Andrew M. Scott may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrew M. Scott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 658 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Antibody therapy of cancer Hit paper breakdown → | 2012 | 1654 |
| 2 | Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes Hit paper breakdown → | 2012 | 953 |
| 3 | 2017 | 313 | |
| 4 | Monoclonal Antibodies for Cancer Therapy Hit paper breakdown → | 2012 | 298 |
| 5 | Antibody–Drug Conjugates for Cancer Therapy Hit paper breakdown → | 2020 | 278 |
| 6 | 2017 | 264 | |
| 7 | 1992 | 240 | |
| 8 | 2007 | 228 | |
| 9 | Radiotheranostics in oncology: current challenges and emerging opportunities Hit paper breakdown → | 2022 | 209 |
| 10 | 1994 | 205 | |
| 11 | 1996 | 176 | |
| 12 | Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor. | 2001 | 174 |
| 13 | 1997 | 165 | |
| 14 | Medical imaging and nuclear medicine: a Lancet Oncology Commission Hit paper breakdown → | 2021 | 161 |
| 15 | 1997 | 153 | |
| 16 | 2006 | 148 | |
| 17 | Monoclonal antibody 806 inhibits the growth of tumor xenografts expressing either the de2-7 or amplified epidermal growth factor receptor (EGFR) but not wild-type EGFR. | 2001 | 146 |
| 18 | 1998 | 143 | |
| 19 | 1991 | 142 | |
| 20 | 2003 | 141 |
About Andrew M. Scott
Andrew M. Scott is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research, having authored 658 papers that have together received 21.4k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (123 papers), Monoclonal and Polyclonal Antibodies Research (113 papers), Medical Imaging Techniques and Applications (105 papers), HER2/EGFR in Cancer Research (71 papers), Radiomics and Machine Learning in Medical Imaging (42 papers), CAR-T cell therapy research (39 papers), Glycosylation and Glycoproteins Research (36 papers) and Cancer, Hypoxia, and Metabolism (35 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (7.4k citations), Oncology (6.0k citations), Cancer Research (2.4k citations), Genetics (1.3k citations) and Immunology (2.5k citations). Andrew M. Scott has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Lloyd J. Old, Jedd D. Wolchok, Hui Gan, Sze Ting Lee, Terrance G. Johns, Antony W. Burgess, Sagun Parakh, Richard J. Simpson, Hong Ji and Edouard C. Nice. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Nuclear Medicine and Molecular Imaging, Journal of Nuclear Medicine, Nuclear Medicine and Biology and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.